Skip to main content
. 2017 Sep 21;8(56):95662–95673. doi: 10.18632/oncotarget.21175

Table 1. Characteristics of the two cohorts of patients with HGSOC.

A: RT/PCR cohort
Median age at diagnosis (range), years 58.5 (25-71)
PTPN13 median expression (range) 1.55 (0.066-14.03)
FIGO stage n (%)
 1-2 6 (22.2)
 3-4 21 (77.78)
Cytoreductive surgery n (%)
 Optimal 11 (39.29)
 Suboptimal 17 (60.71)
Recurrence n (%)
 NO 8 (28.75)
 YES 20 (71.43)
Death n (%)
 NO  9 (32.14)
 YES 19 (67.86)
B: IHC cohort
Median age at diagnosis (range), years 59 (34-85)
PTPN13 n (%)
 IRS 14 (46.67)
 IRS ≥median (IRS=8) 16 (53.33)
FIGO stage n (%)
 1-2 5 (16.67)
 3-4 25 (83.33)
Recurrence n (%)
 NO 6 (20)
 YES 24 (80)
Death n (%)
 NO 4 (13.33)
 YES 26 (86.67)